| Particulars |
|
|
|
| Company Name
| Aurobindo Pharma Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
58.59 |
B.V. (₹) |
335.50 |
| Sales(₹ Cr.) |
10,645.64 |
NP (₹ Cr.) |
1,952.97 |
| NP Var% |
60.00 |
Div% |
450.00 |
| CPS(₹) |
37.70 |
EPS (₹) |
33.30 |
| Traded Value(₹ Lakhs) |
144.12 |
52 Week High |
1,593.00 |
| 52 Week Low |
994.00 |
Price BSE |
1,188.00 |
| Price NSE |
1,188.00 |
Market Capital (₹ Cr.) |
69,615.37 |
| P/C Ratio |
31.50 |
P/E Ratio |
35.60 |
| Price Vs.BV |
3.54 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
2,883.56 |
| NP(₹ Cr.) |
472.05 |
NP Var % |
-24.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
10,713.37 |
| OPM |
23.11 |
NP |
2,069.02 |
| NP Var% |
-0.16 |
EPS |
32.72 |
| PE |
36.31 |
|
|